• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃食管反流病特异性治疗满意度问卷的开发与验证

Development and validation of a disease-specific treatment satisfaction questionnaire for gastro-oesophageal reflux disease.

作者信息

Coyne K S, Wiklund I, Schmier J, Halling K, Degl' Innocenti A, Revicki D

机构信息

MEDTAP International, Bethesda, MD 20814, USA.

出版信息

Aliment Pharmacol Ther. 2003 Nov 1;18(9):907-15. doi: 10.1046/j.1365-2036.2003.01674.x.

DOI:10.1046/j.1365-2036.2003.01674.x
PMID:14616154
Abstract

BACKGROUND

Currently, no disease-specific, patient-based, treatment satisfaction instruments related to gastro-oesophageal reflux disease exist.

AIM

To develop and validate a treatment satisfaction questionnaire for gastro-oesophageal reflux disease (TSQ-G).

METHODS

A new questionnaire was developed from patient focus groups, clinician input and literature review. A validation study was conducted in treated gastro-oesophageal reflux disease patients. Ancillary measures included the Medical Outcomes Study Short Form-36, Quality of Life in Reflux and Dyspepsia, Gastrointestinal Symptom Rating Scale, Socially Desirable Response Scale, Patient Satisfaction Questionnaire-18 and physician and patient measures of symptoms and satisfaction. Statistical analyses included exploratory factor analysis, Cronbach's alpha, intra-class correlations, analyses of variance and t-tests.

RESULTS

A total of 198 gastro-oesophageal reflux disease patients participated in the study, with a mean age of 50.7 years, 68% female and 84% Caucasian. The physician-rated severity of gastro-oesophageal reflux disease was mild (32%), moderate (50%) and severe (18%); 83% were on proton pump inhibitors. The final TSQ-G consisted of 28 items with seven sub-scales; Cronbach's alpha ranged from 0.58 to 0.94. Correlations with the expected sub-scales of the ancillary measures were moderate to strong. The TSQ-G sub-scales discriminated significantly between levels of physician-rated disease severity, symptom days and patient and physician ratings of satisfaction.

CONCLUSIONS

The TSQ-G has excellent reliability and construct validity and appears to be a useful tool for the evaluation of treatment satisfaction in gastro-oesophageal reflux disease patients.

摘要

背景

目前,尚无针对胃食管反流病的、基于患者的疾病特异性治疗满意度评估工具。

目的

开发并验证胃食管反流病治疗满意度问卷(TSQ-G)。

方法

通过患者焦点小组、临床医生意见及文献综述开发了一份新问卷。对接受治疗的胃食管反流病患者进行了验证研究。辅助测量包括医学结局研究简表-36、反流和消化不良生活质量、胃肠道症状评定量表、社会期望反应量表、患者满意度问卷-18以及医生和患者对症状及满意度的测量。统计分析包括探索性因子分析、克朗巴赫α系数、组内相关系数、方差分析和t检验。

结果

共有198例胃食管反流病患者参与研究,平均年龄50.7岁,68%为女性,84%为白种人。医生评定的胃食管反流病严重程度为轻度(32%)、中度(50%)和重度(18%);83%的患者正在使用质子泵抑制剂。最终的TSQ-G由28个项目和7个分量表组成;克朗巴赫α系数范围为0.58至0.94。与辅助测量预期分量表的相关性为中度至高度。TSQ-G分量表在医生评定的疾病严重程度、症状天数以及患者和医生的满意度评分水平之间有显著差异。

结论

TSQ-G具有出色的信度和结构效度,似乎是评估胃食管反流病患者治疗满意度的有用工具。

相似文献

1
Development and validation of a disease-specific treatment satisfaction questionnaire for gastro-oesophageal reflux disease.胃食管反流病特异性治疗满意度问卷的开发与验证
Aliment Pharmacol Ther. 2003 Nov 1;18(9):907-15. doi: 10.1046/j.1365-2036.2003.01674.x.
2
The gastro-oesophageal reflux disease impact scale: a patient management tool for primary care.胃食管反流病影响量表:一种基层医疗的患者管理工具。
Aliment Pharmacol Ther. 2007 Jun 15;25(12):1451-9. doi: 10.1111/j.1365-2036.2007.03343.x.
3
Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test.一份简短的英文和法文问卷在尽管接受质子泵抑制剂治疗但仍有持续上消化道症状的患者中应用的验证:PASS(质子泵抑制剂酸抑制症状)测试
Can J Gastroenterol. 2005 Jun;19(6):350-8. doi: 10.1155/2005/569368.
4
Validation of the treatment satisfaction questionnaire for Crohn's disease (TSQ-C).克罗恩病治疗满意度问卷(TSQ-C)的验证
Dig Dis Sci. 2005 Feb;50(2):252-8. doi: 10.1007/s10620-005-1591-3.
5
International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease.ReQuest在胃镜检查阴性的胃食管反流病患者中的国际验证
Digestion. 2007;75 Suppl 1:48-54. doi: 10.1159/000101082. Epub 2007 May 4.
6
International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease.ReQuest在胃镜检查阴性的胃食管反流病患者中的国际验证
Aliment Pharmacol Ther. 2004 Oct 15;20(8):891-8. doi: 10.1111/j.1365-2036.2004.02194.x.
7
Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease.非糜烂性和轻度糜烂性胃食管反流病急性及维持治疗中的生活质量
Aliment Pharmacol Ther. 2005 Aug 15;22(4):349-56. doi: 10.1111/j.1365-2036.2005.02558.x.
8
Review article: Gastro-oesophageal reflux disease--application of the concept of complete remission.综述文章:胃食管反流病——完全缓解概念的应用
Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:13-6. doi: 10.1111/j.1365-2036.2007.03493.x.
9
Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study.法国胃肠病学家对胃食管反流病的常规管理:一项前瞻性观察研究。
Dig Liver Dis. 2005 Aug;37(8):566-70. doi: 10.1016/j.dld.2005.02.008.
10
Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.法莫替丁和奥美拉唑治疗非糜烂性胃食管反流病症状的疗效:胃食管反流病的随机对照研究
Aliment Pharmacol Ther. 2005 Jun;21 Suppl 2:2-9. doi: 10.1111/j.1365-2036.2005.02467.x.

引用本文的文献

1
Patient-reported outcome measures for medication treatment satisfaction: a systematic review of measure development and measurement properties.患者报告的药物治疗满意度测量指标:测量开发和测量特性的系统评价。
BMC Med. 2024 Sep 2;22(1):347. doi: 10.1186/s12916-024-03560-3.
2
Reliability and Validity of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q) in Persons with Arterial Hypertension.治疗满意度问卷(SATMED-Q)在动脉高血压患者中的信度和效度。
Int J Environ Res Public Health. 2021 Mar 19;18(6):3212. doi: 10.3390/ijerph18063212.
3
Validity and reliability of patient section of evidence-based medical records about doctor-patient building through integrated therapy of traditional Chinese and Western medicine (DPEBMR-P) in patients with gastrointestinal diseases.
中西医结合治疗胃肠道疾病患者医患共建循证医学病历患者部分(DPEBMR-P)的有效性和可靠性
Ann Transl Med. 2019 Mar;7(6):121. doi: 10.21037/atm.2018.12.27.
4
Systematic review: methodological flaws in racial/ethnic reporting for gastroesophageal reflux disease.系统评价:胃食管反流病种族/民族报告中的方法学缺陷
Dis Esophagus. 2018 Mar 1;31(3). doi: 10.1093/dote/dox154.
5
Patient-Centered Outcome Instruments in Esophageal and Gastric Surgery.食管和胃外科以患者为中心的结局指标
J Gastrointest Surg. 2017 Sep;21(9):1515-1522. doi: 10.1007/s11605-017-3451-9. Epub 2017 May 30.
6
Esomeprazole regimens for reflux symptoms in Chinese patients with chronic gastritis.埃索美拉唑治疗中国慢性胃炎患者反流症状的方案
World J Gastroenterol. 2015 Jun 14;21(22):6965-73. doi: 10.3748/wjg.v21.i22.6965.
7
Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database.开发一个在线胃肠道患者报告结局测量库:GI-PRO 数据库。
Am J Gastroenterol. 2014 Feb;109(2):234-48. doi: 10.1038/ajg.2013.401. Epub 2013 Dec 17.
8
Development and validation of the functional assessment of chronic illness therapy treatment satisfaction (FACIT TS) measures.慢性疾病治疗治疗满意度功能评估(FACIT TS)量表的制定与验证。
Qual Life Res. 2014 Apr;23(3):815-24. doi: 10.1007/s11136-013-0520-8. Epub 2013 Sep 24.
9
Patient-reported outcomes in gastroenterology: clinical and research applications.胃肠病学中的患者报告结局:临床和研究应用。
J Neurogastroenterol Motil. 2013 Apr;19(2):137-48. doi: 10.5056/jnm.2013.19.2.137. Epub 2013 Apr 16.
10
Patient satisfaction with medication for gastroesophageal reflux disease: a systematic review.胃食管反流病患者对药物治疗的满意度:一项系统评价。
Can J Gastroenterol. 2012 Apr;26(4):196-204. doi: 10.1155/2012/235476.